- Open
- 0.33
- High
- 0.33
- Low
- 0.30
- Close
- 0.33
- Change
- -0.03 (-7.69%)
- Volume
- 23,412,204
| 7 Oct 2026 | 07:00:04 | Notice of Results, Analyst & Investor Presentation |
| 20 Aug 2026 | 07:00:07 | Appointment of Joint Corporate Broker |
| 14 Aug 2026 | 07:00:03 | Director Fee Shares and Grant of Options |
| 13 Jul 2026 | 07:00:09 | Trading Update |
| 8 Jul 2026 | 07:00:03 | Aptamer initiates Ebola diagnostic test programme |
| 16 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 19 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 12 Jan 2024 | Annual Report and Accounts (to 2023-06-30) |
Aptamer Group plc provides aptamer selection and development services, focusing on the creation of aptamer-based reagents. The company operates through three divisions: custom services, diagnostics, and therapeutics. Its business model involves offering research and bioprocessing tools to various sectors within the life sciences, serving customers in therapeutic, diagnostic, and target-binding applications globally.
| 7 Oct 2026 | 07:00:04 | Notice of Results, Analyst & Investor Presentation |
| 20 Aug 2026 | 07:00:07 | Appointment of Joint Corporate Broker |
| 14 Aug 2026 | 07:00:03 | Director Fee Shares and Grant of Options |
| 13 Jul 2026 | 07:00:09 | Trading Update |
| 8 Jul 2026 | 07:00:03 | Aptamer initiates Ebola diagnostic test programme |
| 16 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 19 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 12 Jan 2024 | Annual Report and Accounts (to 2023-06-30) |
Aptamer Group plc provides aptamer selection and development services, focusing on the creation of aptamer-based reagents. The company operates through three divisions: custom services, diagnostics, and therapeutics. Its business model involves offering research and bioprocessing tools to various sectors within the life sciences, serving customers in therapeutic, diagnostic, and target-binding applications globally.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £171m | +0.2% | |
| £13m | -0.3% | |
| £12m | +3.5% | |
| £12m | +0.0% | |
APTAAptamer Group plc | £7m | -0.7% |
| £6m | -0.5% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £171m | +0.2% | |
| £13m | -0.3% | |
| £12m | +3.5% | |
| £12m | +0.0% | |
APTAAptamer Group plc | £7m | -0.7% |
| £6m | -0.5% |
